Terms: = Sarcomas AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
434 results:
1. Circ_0002669 promotes osteosarcoma tumorigenesis through directly binding to MYCBP and sponging miR-889-3p.
Zhang Y; Zhan Y; Liu Z; Guo H; Liu D; Chen C
Biol Direct; 2024 Apr; 19(1):25. PubMed ID: 38570856
[TBL] [Abstract] [Full Text] [Related]
2. Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in
Jansen RA; Mainardi S; Dias MH; Bosma A; van Dijk E; Selig R; Albrecht W; Laufer SA; Zender L; Bernards R
Proc Natl Acad Sci U S A; 2024 Feb; 121(9):e2319492121. PubMed ID: 38377196
[TBL] [Abstract] [Full Text] [Related]
3. Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma.
Wei L; Meng J; Xiang D; Yang Q; Zhou Y; Xu L; Wang M; Chen J; Han Y
BMC Complement Med Ther; 2024 Jan; 24(1):67. PubMed ID: 38297292
[TBL] [Abstract] [Full Text] [Related]
4. [Bioinformatics analysis and identification to immune-related markers of osteoporosis].
Sun J; Cong S; Luo L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1108-1113. PubMed ID: 38140871
[TBL] [Abstract] [Full Text] [Related]
5. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
6. Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis.
Park C; Kim R; Choi J; Kim M; Kim TM; Han I; Kim JI; Kim HS
Cancer Res Treat; 2024 Apr; 56(2):665-674. PubMed ID: 37752792
[TBL] [Abstract] [Full Text] [Related]
7. Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.
Croushore EE; Koppenhafer SL; Goss KL; Geary EL; Gordon DJ
Cancer Res Commun; 2023 Aug; 3(8):1580-1593. PubMed ID: 37599787
[TBL] [Abstract] [Full Text] [Related]
8. Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking.
Wang Y; Tao X; Gao Y; Jin Z; Guo S; Li Z; Wang M; Zhao R; Zhou W; Wu J
Medicine (Baltimore); 2023 Jul; 102(29):e34030. PubMed ID: 37478234
[TBL] [Abstract] [Full Text] [Related]
9. Study on the mechanism of Baihe Dihuang decoction in treating menopausal syndrome based on network pharmacology.
Tian M; Yang A; Lu Q; Zhang X; Liu G; Liu G
Medicine (Baltimore); 2023 May; 102(20):e33189. PubMed ID: 37335709
[TBL] [Abstract] [Full Text] [Related]
10. Butein, a potential drug for the treatment of bone cancer pain through bioinformatic and network pharmacology.
Liu X; Zhao S; Zhao Q; Chen Y; Jia S; Xiang R; Zhang J; Sun J; Xu Y; Zhao M
Toxicol Appl Pharmacol; 2023 Aug; 472():116570. PubMed ID: 37268026
[TBL] [Abstract] [Full Text] [Related]
11. Cachexia causes time-dependent activation of the inflammasome in the liver.
das Neves RX; Yamashita AS; Riccardi DMR; Köhn-Gaone J; Camargo RG; Neto NI; Caetano D; Gomes SP; Santos FH; Lima JDCC; Batista ML; Rosa-Neto JC; Martins De Alcântara PS; Maximiano LF; Otoch JP; Trinchieri G; Tirnitz-Parker JEE; Seelaender M
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1621-1630. PubMed ID: 37177862
[TBL] [Abstract] [Full Text] [Related]
12. Apoptotic effect and cell arrest of deoxyshikonin in human osteosarcoma cells through the p38 pathway.
Hsieh MC; Hsieh YH; Chou CH; Yang JS; Lu PW; Huang TY; Yang SF; Lu KH
J Cell Mol Med; 2023 Jun; 27(11):1592-1602. PubMed ID: 37155410
[TBL] [Abstract] [Full Text] [Related]
13. Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing.
Kamolphiwong R; Kanokwiroon K; Wongrin W; Chaiyawat P; Klangjorhor J; Settakorn J; Teeyakasem P; Sangphukieo A; Pruksakorn D
Gene; 2023 Mar; 856():147106. PubMed ID: 36513192
[TBL] [Abstract] [Full Text] [Related]
14. LANA regulates miR-155/GATA3 signaling axis by enhancing c-jun/c-Fos interaction to promote the proliferation and migration of KSHV-infected cells.
Luo T; Pan Y; Liu Y; Zheng J; Zhuang Z; Ren Z; Zhu J; Gu Y; Zeng Y
J Med Virol; 2023 Jan; 95(1):e28255. PubMed ID: 36284455
[TBL] [Abstract] [Full Text] [Related]
15. Non-urothelial lesions of the urinary bladder A 14.5-year, single-institution review.
Caputo A; Califano A; Addesso M; Caleo A; Zeppa P; D'Antonio A
Pathol Res Pract; 2022 Sep; 237():153998. PubMed ID: 35843032
[TBL] [Abstract] [Full Text] [Related]
16. Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1.
Kim JA; Berlow NE; Lathara M; Bharathy N; Martin LR; Purohit R; Cleary MM; Liu Q; Michalek JE; Srinivasa G; Cole BL; Chen SD; Keller C
Biochem Biophys Res Commun; 2022 Sep; 621():101-108. PubMed ID: 35820279
[TBL] [Abstract] [Full Text] [Related]
17. Tanshinol suppresses osteosarcoma by specifically inducing apoptosis of U2-OS cells through p53-mediated mechanism.
Yu S; Guo L; Yan B; Yuan Q; Shan L; Zhou L; Efferth T
J Ethnopharmacol; 2022 Jun; 292():115214. PubMed ID: 35331874
[TBL] [Abstract] [Full Text] [Related]
18. Effects of butein on human osteosarcoma cell proliferation, apoptosis, and autophagy through oxidative stress.
Zhang P; Zhang J; Quan H; Chen P; Wang J; Liang Y
Hum Exp Toxicol; 2022; 41():9603271221074346. PubMed ID: 35130734
[TBL] [Abstract] [Full Text] [Related]
19. Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma.
Chen R; Guan Z; Zhong X; Zhang W; Zhang Y
Comput Math Methods Med; 2022; 2022():3197402. PubMed ID: 35069780
[TBL] [Abstract] [Full Text] [Related]
20. ε-Viniferin and α-viniferin alone or in combination induced apoptosis and necrosis in osteosarcoma and non-small cell lung cancer cells.
Huang C; Lin ZJ; Lee CJ; Lai WH; Chen JC; Huang HC
Food Chem Toxicol; 2021 Dec; 158():112617. PubMed ID: 34728247
[TBL] [Abstract] [Full Text] [Related]
[Next]
